Understanding how smokeless tobacco marketing affects consumer behavior
Assessment of consumer response to smokeless tobacco modified risk marketing orders
This study looks at how people feel about marketing messages that say some smokeless tobacco products are safer than regular cigarettes, especially since the FDA has allowed certain brands to make these claims, and it aims to understand how this might affect people's health choices.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Roswell Park Cancer Institute Corp NIH-funded |
| Lab location | 1 site (Buffalo, United States) |
| Project ID | NIH-10856326 on NIH RePORTER |
What this research studies
This research investigates how consumers respond to marketing claims about smokeless tobacco products that suggest they are less harmful than traditional cigarettes. It focuses on the recent FDA authorizations that allow certain smokeless tobacco brands to advertise reduced risk claims. By examining consumer beliefs and perceptions, the study aims to understand the potential impact of these marketing strategies on public health and tobacco use behaviors. Participants will be assessed on their awareness and reactions to these claims, providing insights into their effectiveness.
Who could benefit from this research
Good fit: Ideal candidates for this research include adults over 21 who currently use tobacco products or are considering switching from cigarettes to smokeless tobacco.
Not a fit: Patients who do not use tobacco products or are under 21 years old may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could inform public health strategies and regulatory policies regarding tobacco marketing and harm reduction.
How similar studies have performed: Previous research has shown that marketing claims can significantly influence consumer behavior, suggesting that this approach may yield valuable insights.
Where this research is happening
Buffalo, United States
- Roswell Park Cancer Institute Corp — Buffalo, United States (Active)
Researchers
- Principal investigator: O'connor, Richard J — Roswell Park Cancer Institute Corp
- Study coordinator: O'connor, Richard J
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.